Molecular Mechanisms of Antibacterial Multidrug Resistance

Cell

Volumn 128, Issue 6, 2007, Pages 1037-1050

  Alekshun, Michael N ^a   Levy, Stuart B ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Ctr Adaptation Genet Drug Resist   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CARBAPENEM; CHLORAMPHENICOL; CLAVULANIC ACID; DAPTOMYCIN; ERYTHROMYCIN; ETHAMBUTOL; FLORFENICOL; GENTAMICIN; ISONIAZID; KANAMYCIN; LINCOSAMIDE; LINEZOLID; MACROLIDE; PENICILLIN G; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RIFAMYCIN; RIFAPENTINE; STREPTOGRAMIN; STREPTOMYCIN; SULFONAMIDE; TELITHROMYCIN; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; CAUSAL ATTRIBUTION; CHROMOSOME DUPLICATION; CHROMOSOME MUTATION; DRUG MECHANISM; DRUG PENETRATION; ENZYME MECHANISM; GENE AMPLIFICATION; GENE TRANSFER; GENETIC ASSOCIATION; GENOME; HUMAN; INTEGRON; MICROORGANISM; MULTIDRUG RESISTANCE; NONHUMAN; PHARMACOGENETICS; PHENOTYPE; PLASMID; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; TRANSPOSON; TREATMENT FAILURE; TUBERCULOSIS;

EID: 33947260230     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2007.03.004     Document Type: Review

References (82)

1. Alangaden G.J., Kreiswirth B.N., Aouad A., Khetarpal M., Igno F.R., Moghazeh S.L., Manavathu E.K., and Lerner S.A. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42 (1998) 1295-1297
2. Albertson D.G. Gene amplification in cancer. Trends Genet. 22 (2006) 447-455
3. Alekshun M.N., and Levy S.B. Bacterial drug resistance: response to survival threats. In: Storz G., and Hengge-Aronis R. (Eds). Bacterial Stress Responses (2000), ASM Press, Washington, D.C. 323-366
4. Barber M. Staphylococci infection due to penicillin-resistant strains. BMJ 2 (1947) 863-865
5. Barber M. Methicillin-resistant staphylococci. J. Clin. Pathol. 14 (1961) 385-393
6. Barbosa T.M., and Levy S.B. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J. Bacteriol. 182 (2000) 3467-3474
7. Chesneau O., Ligeret H., Hosan-Aghaie N., Morvan A., and Dassa E. Molecular analysis of resistance to streptogramin A compounds conferred by the Vga proteins of staphylococci. Antimicrob. Agents Chemother. 49 (2005) 973-980
8. Connell S.R., Tracz D.M., Nierhaus K.H., and Taylor D.E. Ribosomal protection proteins and their mechanism of tetracycline resistance. Antimicrob. Agents Chemother. 47 (2003) 3675-3681
9. Cook M., Molto E., and Anderson C. Fluorochrome labeling in Roman period skeletons from Dakhleh Oasis. Egypt. Am. J. Phys. Anthropol. 80 (1989) 137-143
10. Courvalin P. Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 38 (1994) 1447-1451
11. Courvalin P. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42 Suppl 1 (2006) S25-S34
12. Cui L., Iwamoto A., Lian J.Q., Neoh H.M., Maruyama T., Horikawa Y., and Hiramatsu K. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50 (2006) 428-438
13. Cui L., Tominaga E., Neoh H.M., and Hiramatsu K. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50 (2006) 1079-1082
14. Davies J., and Wright G.D. Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 5 (1997) 234-240
15. D'Costa V.M., McGrann K.M., Hughes D.W., and Wright G.D. Sampling the antibiotic resistome. Science 311 (2006) 374-377
16. Diep B.A., Gill S.R., Chang R.F., Phan T.H., Chen J.H., Davidson M.G., Lin F., Lin J., Carleton H.A., Mongodin E.F., et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367 (2006) 731-739
17. Drlica K., and Malik M. Fluoroquinolones: action and resistance. Curr. Top. Med. Chem. 3 (2003) 249-282
18. Falagas M.E., and Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40 (2005) 1333-1341
19. Friedman L., Alder J.D., and Silverman J.A. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 50 (2006) 2137-2145
20. Fuda C.C., Fisher J.F., and Mobashery S. Beta-lactam resistance in Staphylococcus aureus: the adaptive resistance of a plastic genome. Cell. Mol. Life Sci. 62 (2005) 2617-2633
21. Gerrits M.M., de Zoete M.R., Arents N.L., Kuipers E.J., and Kusters J.G. 16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 46 (2002) 2996-3000
22. Grkovic S., Brown M.H., and Skurray R.A. Regulation of bacterial drug export systems. Microbiol. Mol. Biol. Rev. 66 (2002) 671-701
23. Hagman K.E., Pan W., Spratt B.G., Balthazar J.T., Judd R.C., and Shafer W.M. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiol. 141 (1995) 611-622
24. Hayden M.K., Rezai K., Hayes R.A., Lolans K., Quinn J.P., and Weinstein R.A. Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 43 (2005) 5285-5287
25. Hegde S.S., Vetting M.W., Roderick S.L., Mitchenall L.A., Maxwell A., Takiff H.E., and Blanchard J.S. A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. Science 308 (2005) 1480-1483
26. Hershberger E., Donabedian S., Konstantinou K., and Zervos M.J. Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin. Infect. Dis. 38 (2004) 92-98
27. Hiramatsu K., Aritaka N., Hanaki H., Kawasaki S., Hosoda Y., Hori S., Fukuchi Y., and Kobayashi I. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350 (1997) 1670-1673
28. Hirata T., Saito A., Nishino K., Tamura N., and Yamaguchi A. Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936). Antimicrob. Agents Chemother. 48 (2004) 2179-2184
29. Hisanaga T., Hoban D.J., and Zhanel G.G. Mechanisms of resistance to telithromycin in Streptococcus pneumoniae. J. Antimicrob. Chemother. 56 (2005) 447-450
30. Jacobs M.R. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices. Am. J. Med. 106 (1999) 19S-25S
31. Jacoby G.A., and Munoz-Price L.S. The new beta-lactamases. N. Engl. J. Med. 352 (2005) 380-391
32. Levin A.S., Barone A.A., Penco J., Santos M.V., Marinho I.S., Arruda E.A., Manrique E.I., and Costa S.F. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28 (1999) 1008-1011
33. Levy S.B. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36 (1992) 695-703
34. Levy S.B. The Antibiotic Paradox: How the Misuse of Antibiotics Destroys Their Curative Powers (2002), Perseus Publishing, Cambridge, MA
35. Levy S.B., and Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10 (2004) S122-S129
36. Levy S.B., Fitzgerald G.B., and Macone A.B. Spread of antibiotic-resistance plasmids from chicken to chicken and from chicken to man. Nature 260 (1976) 40-42
37. Li X.Z., and Nikaido H. Efflux-mediated drug resistance in bacteria. Drugs 64 (2004) 159-204
38. Lomovskaya O., Lee A., Hoshino K., Ishida H., Mistry A., Warren M.S., Boyer E., Chamberland S., and Lee V.J. Use of a genetic approach to evaluate the consequences of inhibition of efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43 (1999) 1340-1346
39. Martinez-Martinez L., Pascual A., and Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 351 (1998) 797-799
40. Matsuoka M., and Sasaki T. Inactivation of macrolides by producers and pathogens. Curr. Drug Targets Infect. Disord. 4 (2004) 217-240
41. Matthews P.R., and Stewart P.R. Amplification of a section of chromosomal DNA in methicillin-resistant Staphylococcus aureus following growth in high concentrations of methicillin. J. Gen. Microbiol. 134 (1988) 1455-1464
42. Mazel D. Integrons: agents of bacterial evolution. Nat. Rev. Microbiol. 4 (2006) 608-620
43. Mazel D., Dychinco B., Webb V.A., and Davies J. A distinctive class of integron in the Vibrio cholerae genome. Science 280 (1998) 605-608
44. McMurry L., Petrucci Jr. R.E., and Levy S.B. Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli. Proc. Natl. Acad. Sci. USA 77 (1980) 3974-3977
45. Meka V.G., and Gold H.S. Antimicrobial resistance to linezolid. Clin. Infect. Dis. 39 (2004) 1010-1015
46. Miller L.G., Perdreau-Remington F., Rieg G., Mehdi S., Perlroth J., Bayer A.S., Tang A.W., Phung T.O., and Spellberg B. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N. Engl. J. Med. 352 (2005) 1445-1453
47. Moore I.F., Hughes D.W., and Wright G.D. Tigecycline is modified by the flavin-dependent monooxygenase TetX. Biochemistry 44 (2005) 11829-11835
48. Murakami S., and Yamaguchi A. Multidrug-exporting secondary transporters. Curr. Opin. Struct. Biol. 13 (2003) 443-452
49. Musher D.M., Dowell M.E., Shortridge V.D., Flamm R.K., Jorgensen J.H., Le Magueres P., and Krause K.L. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N. Engl. J. Med. 346 (2002) 630-631
50. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., Johnson S.K., Vandenesch F., Fridkin S., O'Boyle C., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
51. Neyfakh A.A., Bidnenko V., and Chen L.B. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with mammalian systems. Proc. Natl. Acad. Sci. USA 88 (1991) 4781-4785
52. Nicoloff H., Perreten V., McMurry L.M., and Levy S.B. Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB. J. Bacteriol. 188 (2006) 4413-4423
53. Nicoloff H., Perreten V., and Levy S.B. Increased genome instability in Escherichia coli lon mutants: relation to emergence of multiple antibiotic resistant (Mar) mutants caused by insertion sequence elements and large tandem genomic amplifications. Antimicrob. Agents Chemother. (2007) 10.1128/AAC.01128-06 Published online January 12, 2007
54. Noble W.C., Virani Z., and Cree R.G. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett. 72 (1992) 195-198
55. Ochs M.M., McCusker M.P., Bains M., and Hancock R.E.W. Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids. Antimicrob. Agents Chemother. 43 (1999) 1085-1090
56. Oethinger M., Kern W.V., Jellen-Ritter A.S., McMurry L.M., and Levy S.B. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44 (2000) 10-13
57. Perreten V., and Boerlin P. A new sulfonamide resistance gene (sul3) in Escherichia coli is widespread in the pig population of Switzerland. Antimicrob. Agents Chemother. 47 (2003) 1169-1172
58. Pesci E.C., Milbank J.B.J., Pearson J.P., McKnight S., Kende A.S., Greenberg E.P., and Iglewski B.H. Quinolone signaling in the cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 96 (1999) 11229-11234
59. Poirel L., Lambert T., Turkoglu S., Ronco E., Gaillard J., and Nordmann P. Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob. Agents Chemother. 45 (2001) 546-552
60. Roberts M.C. Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics. Mol. Biotechnol. 28 (2004) 47-62
61. Robicsek A., Strahilevitz J., Jacoby G.A., Macielag M., Abbanat D., Park C.H., Bush K., and Hooper D.C. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12 (2006) 83-88
62. Ross J.I., Eady E.A., Cove J.H., and Cunliffe W.J. 16S rRNA mutation associated with tetracycline resistance is a gram-positive bacterium. Antimicrob. Agents Chemother. 52 (1998) 1702-1705
63. Ruzin A., Visalli M.A., Keeney D., and Bradford P.A. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 49 (2005) 1017-1022
64. Sapunaric F.M., Aldema-Ramos M., and McMurry L.M. Tetracycline resistance: efflux, mutation, and other mechanisms. In: White D.G., Alekshun M.N., and McDermott P.F. (Eds). Frontiers in Antimicrobial Resistance: A Tribute to Stuart B. Levy (2005), ASM Press, Washington, DC 3-18
65. Schneiders T., Amyes S.G., and Levy S.B. Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob. Agents Chemother. 47 (2003) 2831-2837
66. Schumacher M.A., and Brennan R.G. Structural mechanisms of multidrug recognition and regulation by bacterial multidrug transcription factors. Mol. Microbiol. 45 (2002) 885-893
67. Schwarz S., Kehrenberg C., Doublet B., and Cloeckaert A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. 28 (2004) 519-542
68. Sharma S.K., and Mohan A. Multidrug-resistant tuberculosis: A menace that threatens to destabilize tuberculosis control. Chest 130 (2006) 261-272
69. Skold O. Resistance to trimethoprim and sulfonamides. Vet. Res. 32 (2001) 261-273
70. Sloan J., McMurry L.M., Lyras D., Levy S.B., and Rood J.I. The Clostridium perfringens Tet P determinant comprises two overlapping genes: tetA(P), which mediates active tetracycline efflux, and tetB(P), which is related to the ribosomal protection family of tetracycline-resistance determinants. Mol. Microbiol. 11 (1994) 403-415
71. Stanton T.B., and Humphrey S.B. Isolation of tetracycline-resistant Megasphaera elsdenii strains with novel mosaic gene combinations of tet(O) and tet(W) from swine. Appl. Environ. Microbiol. 69 (2003) 3874-3882
72. Stein G.E., and Craig W.A. Tigecycline: A critical analysis. Clin. Infect. Dis. 43 (2006) 518-524
73. Tait-Kamradt A., Davies T., Appelbaum P.C., Depardieu F., Courvalin P., Petitpas J., Wondrack L., Walker A., Jacobs M.R., and Sutcliffe J. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 44 (2000) 3395-3401
74. Tennent J.M., Lyon B.R., Midgley M., Jones I.G., Purewal A.S., and Skurray R.A. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J. Gen. Microbiol. 135 (1989) 1-10
75. Tran J.H., and Jacoby G.A. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA 99 (2002) 5638-5642
76. Watanabe T. Infective heredity of multiple drug resistance in bacteria. Bacteriol. Rev. 27 (1963) 87-115
77. Weigel L.M., Clewell D.B., Gill S.R., Clark N.C., McDougal L.K., Flannagan S.E., Kolonay J.F., Shetty J., Killgore G.E., and Tenover F.C. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302 (2003) 1569-1571
78. Weisblum B. Macrolide resistance. Drug Resist. Updat. 1 (1998) 29-41
79. Wilson P., Andrews J.A., Charlesworth R., Walesby R., Singer M., Farrell D.J., and Robbins M. Linezolid resistance in clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 51 (2003) 186-188
80. Wolter N., Smith A.M., Farrell D.J., Schaffner W., Moore M., Whitney C.G., Jorgensen J.H., and Klugman K.P. Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob. Agents Chemother. 49 (2005) 3554-3557
81. Woolridge D.P., Vazquez-Laslop N., Markham P.N., Chevalier M.S., Gerner E.W., and Neyfakh A.A. Efflux of the natural polyamine spermidine facilitated by the Bacillus subtilis multidrug transporter Blt. J. Biol. Chem. 272 (1997) 8864-8866
82. Zhanel G.G., Dueck M., Hoban D.J., Vercaigne L.M., Embil J.M., Gin A.S., and Karlowsky J.A. Review of macrolides and ketolides: focus on respiratory tract infections. Drugs 61 (2001) 443-498